Hongyuan Pharmaceutical: CFO Zeng Kefeng resigns, Chairman will assume responsibilities.

Hongyuan Pharmaceutical announced that the company's Chief Financial Officer, Zeng Kefeng, has resigned for personal reasons. The resignation will take effect from the date of submission to the Board of Directors. He has completed the handover of work and will not hold any position in the company after resigning. The Chairman and General Manager, Yin Dan, will assume the responsibilities of the Chief Financial Officer until a new appointee takes office. Zeng Kefeng's original term was until the expiration of the fifth session of the Board of Directors. As of the date of the announcement, he held 292,500 shares of the company, accounting for 0.07% of the total share capital. After resigning, he will continue to comply with the regulations on share transfer and relevant commitments.